- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股处于空头行情中，可能有短期反弹。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有37家主力机构披露2025-12-31报告期持股数据，持仓量总计403.42万股，占流通A股1.48%
- 波段诊断：
-
技术面诊股
诊断结果：5.0技术面打败了22%的股票
技术面评分前10的股票
近期的平均成本为11.15元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为11.15元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"11.15","date":1776759381,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.04.22","stock":"-0.98","trade":null,"ind":"1.30"},{"date":"2026.04.21","stock":"-1.49","trade":null,"ind":"0.10"},{"date":"2026.04.20","stock":"0.18","trade":null,"ind":"0.55"},{"date":"2026.04.17","stock":"-1.81","trade":null,"ind":"0.60"},{"date":"2026.04.16","stock":"0.26","trade":null,"ind":"2.05"},{"date":"2026.04.15","stock":"-1.19","trade":null,"ind":"-0.97"},{"date":"2026.04.14","stock":"-0.51","trade":null,"ind":"1.61"},{"date":"2026.04.13","stock":"-0.25","trade":null,"ind":"0.69"},{"date":"2026.04.10","stock":"1.72","trade":null,"ind":"2.24"},{"date":"2026.04.09","stock":"-2.02","trade":null,"ind":"-0.33"},{"date":"2026.04.08","stock":"1.89","trade":null,"ind":"4.79"},{"date":"2026.04.07","stock":"2.46","trade":null,"ind":"0.36"},{"date":"2026.04.03","stock":"-2.99","trade":null,"ind":"-0.99"},{"date":"2026.04.02","stock":"-1.43","trade":null,"ind":"-1.60"},{"date":"2026.04.01","stock":"1.80","trade":null,"ind":"1.70"},{"date":"2026.03.31","stock":"0.17","trade":null,"ind":"-1.81"},{"date":"2026.03.30","stock":"0.17","trade":null,"ind":"-0.25"},{"date":"2026.03.27","stock":"2.56","trade":null,"ind":"1.13"},{"date":"2026.03.26","stock":"-1.48","trade":null,"ind":"-1.41"},{"date":"2026.03.25","stock":"-0.78","trade":null,"ind":"1.95"},{"date":"2026.03.24","stock":"5.55","trade":null,"ind":"1.43"}]
迪瑞医疗,深证成指,医疗器械指数
压力支撑
该股压力位为11.17元，支撑位为11.05元。
[{"text":"\u538b\u529b\u4f4d","value":"11.17","date":1776787200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"11.05","date":1776787200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.9资金面打败了59%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月22日 20:30
| 机构今日流向(万元) | 461.81 | 机构5日流向(万元) | -1755.27 |
| 机构10日流向(万元) | -5674.04 | 机构20日流向(万元) | -6621.93 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少11101.46万股，其中基金净增仓4家，主力净减仓6家，暂未发现中长期投资价值。
截止2025-12-31，共37家主力机构（基金37家），持仓量总计403.42万股，占流通A股1.48%
其中，基金持仓与2025-06-30相比：
增仓：12家 ，增持 81.51万股
减仓：8家 ，减持 1.82万股
新出现在主力名单中：13家 ，持有253.3万股
从主力名单中消失：19家 ，原持有11434.45万股
其中，基金持仓与2025-06-30相比：
增仓：12家 ，增持 81.51万股
减仓：8家 ，减持 1.82万股
新出现在主力名单中：13家 ，持有253.3万股
从主力名单中消失：19家 ，原持有11434.45万股
消息面诊股
诊断结果：5消息面打败了31%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 强化保密意识 筑牢安全防线 迪瑞医疗开展2026年
2026-04-20 - 迪瑞医疗（截止2026年4月10日）股东人数为16
2026-04-15 - 医药行业派2025年成绩单 盈利标尺下的“冰火两重
2026-04-14 - 迪瑞医疗（截止2026年3月20日）股东人数为16
2026-03-27 - 迪瑞医疗（截止2026年3月10日）股东人数为16
2026-03-12 - 地缘冲突持续，体外诊断板块中东出海影响几何？
2026-03-06 - 华润集团韩跃伟副总经理一行调研迪瑞医疗
2026-03-05 - 迪瑞医疗（截止2026年2月27日）股东人数为15
2026-03-04 - 迪瑞医疗：郭霆先生因个人工作安排原因辞去公司董事及
2026-03-04 - 开春第一变！药企高管集体“大换血”
2026-03-03
消息列表
| 一般消息 | 高管变动 | 因工作安排原因 | 2026-03-12 |
| 一般消息 | 高管变动 | 因个人工作安排 | 2026-02-27 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2026-02-05 |
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-30 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-30 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-10-24 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-09-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 高管变动 | 因部分董事在股东方及关联单位任职发... | 2025-08-07 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：0.0行业面打败了1%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.04.22","price":"1.30","value":null},{"date":"2026.04.21","price":"0.10","value":null},{"date":"2026.04.20","price":"0.55","value":null},{"date":"2026.04.17","price":"0.60","value":null},{"date":"2026.04.16","price":"2.05","value":null},{"date":"2026.04.15","price":"-0.97","value":null},{"date":"2026.04.14","price":"1.61","value":null},{"date":"2026.04.13","price":"0.69","value":null},{"date":"2026.04.10","price":"2.24","value":null},{"date":"2026.04.09","price":"-0.33","value":null},{"date":"2026.04.08","price":"4.79","value":null},{"date":"2026.04.07","price":"0.36","value":null},{"date":"2026.04.03","price":"-0.99","value":null},{"date":"2026.04.02","price":"-1.60","value":null},{"date":"2026.04.01","price":"1.70","value":null},{"date":"2026.03.31","price":"-1.81","value":null},{"date":"2026.03.30","price":"-0.25","value":null},{"date":"2026.03.27","price":"1.13","value":null},{"date":"2026.03.26","price":"-1.41","value":null},{"date":"2026.03.25","price":"1.95","value":null},{"date":"2026.03.24","price":"1.43","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 海泰新光 | 157.68% | 38.65% | 6.2分 |
| 2 | 力诺药包 | 72.13% | 16.58% | 5.4分 |
| 3 | 九安医疗 | 44.77% | 16.55% | 5.0分 |
| 4 | 英诺特 | 32.86% | 11.93% | 5.9分 |
| 5 | 康众医疗 | 31.75% | 12.83% | 5.5分 |
| 6 | 宝莱特 | 24.73% | 0.86% | 4.9分 |
| 8 | 麦澜德 | 19.48% | 4.57% | 6.3分 |
| 10 | 伟思医疗 | 16.53% | 4.34% | 6.3分 |
| 12 | ST凯利 | 16.35% | 1.94% | 5.2分 |
| 14 | 微电生理 | 16.20% | -0.08% | 4.8分 |
| 16 | 济民健康 | 15.62% | -1.34% | 4.3分 |
| 18 | 五洲医疗 | 13.42% | 5.39% | 5.0分 |
| 20 | 阳普医疗 | 12.48% | 8.83% | 5.1分 |
| 22 | 惠泰医疗 | 11.41% | -2.62% | 5.7分 |
| 24 | 山外山 | 11.07% | 0.88% | 6.1分 |
| 26 | 硕世生物 | 10.44% | 22.15% | 4.6分 |
| 28 | 爱迪特 | 9.83% | 14.47% | 6.0分 |
| 30 | 正川股份 | 9.65% | 1.19% | 4.7分 |
| 32 | - | 9.35% | 7.80% | 分 |
| 34 | 海尔生物 | 9.25% | 2.78% | 5.6分 |
| 36 | 翔宇医疗 | 8.20% | 1.98% | 5.2分 |
| 38 | 北芯生命 | 7.83% | -4.31% | 5.0分 |
| 40 | 佰仁医疗 | 7.50% | 8.34% | 5.8分 |
| 42 | - | 7.31% | 0.69% | 分 |
| 44 | 天臣医疗 | 6.77% | 0.18% | 5.8分 |
| 46 | 大博医疗 | 6.48% | 0.95% | 5.2分 |
| 48 | 港通医疗 | 6.36% | 2.03% | 5.2分 |
| 50 | 麦克奥迪 | 6.01% | 1.61% | 5.0分 |
| 52 | 瑞迈特 | 5.87% | 1.78% | 5.4分 |
| 54 | 利德曼 | 5.29% | 0.74% | 4.6分 |
| 56 | 热景生物 | 4.90% | -8.93% | 3.3分 |
| 58 | 南微医学 | 4.69% | -1.13% | 5.5分 |
| 60 | 国发股份 | 4.62% | 6.25% | 4.6分 |
| 62 | - | 4.43% | 2.59% | 分 |
| 64 | - | 4.22% | 3.43% | 分 |
| 66 | 山东药玻 | 4.02% | 2.51% | 5.3分 |
| 68 | 万东医疗 | 3.85% | 1.09% | 4.9分 |
| 70 | 睿昂基因 | 3.79% | 1.51% | 4.7分 |
| 72 | 艾德生物 | 3.68% | -2.17% | 5.1分 |
| 74 | 健帆生物 | 3.55% | 3.61% | 5.0分 |
| 76 | 可孚医疗 | 3.34% | -3.84% | 6.0分 |
| 78 | 安旭生物 | 3.16% | -2.08% | 4.4分 |
| 80 | 康德莱 | 2.74% | -3.03% | 5.4分 |
| 82 | 爱威科技 | 2.60% | 3.18% | 5.9分 |
| 84 | - | 2.52% | 1.16% | 分 |
| 86 | 中红医疗 | 1.97% | 5.24% | 5.0分 |
| 88 | 祥生医疗 | 1.83% | -0.61% | 5.3分 |
| 90 | 爱博医疗 | 1.64% | 0.94% | 5.1分 |
| 92 | 九强生物 | 1.54% | -1.82% | 4.2分 |
| 94 | 凯普生物 | 1.11% | -8.73% | 4.0分 |
| 96 | 威高血净 | 0.89% | -0.61% | 5.6分 |
| 98 | 新华医疗 | 0.42% | -1.80% | 4.5分 |
| 100 | 欧普康视 | -0.21% | 0.14% | 5.0分 |
| 102 | 昊海生科 | -0.49% | -0.77% | 5.5分 |
| 104 | 正海生物 | -0.95% | -6.46% | 4.9分 |
| 106 | 达安基因 | -1.36% | -2.84% | 4.8分 |
| 108 | - | -1.52% | 0.72% | 分 |
| 110 | 圣湘生物 | -2.24% | -2.08% | 5.0分 |
| 112 | 奥精医疗 | -2.49% | -4.69% | 4.8分 |
| 114 | 蓝帆医疗 | -2.55% | 1.60% | 5.2分 |
| 116 | 尚荣医疗 | -2.87% | -2.03% | 5.1分 |
| 118 | 易瑞生物 | -3.04% | -1.78% | 5.0分 |
| 120 | 冠昊生物 | -3.18% | -3.30% | 4.8分 |
| 122 | 迪瑞医疗 | -3.88% | -3.80% | 4.3分 |
| 124 | 济高发展 | -4.28% | -1.02% | 4.6分 |
| 126 | 迈普医学 | -4.70% | -0.60% | 5.8分 |
| 128 | 亚辉龙 | -5.70% | -5.20% | 3.6分 |
| 130 | 万孚生物 | -6.54% | -1.97% | 3.7分 |
| 132 | 南卫股份 | -8.06% | 1.11% | 5.4分 |
| 134 | 新产业 | -8.60% | -0.57% | 5.2分 |
| 136 | 中源协和 | -10.32% | -1.71% | 4.3分 |
| 138 | 维力医疗 | -12.11% | -5.84% | 5.2分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 122/242 ， 102/242。
[{"date":"2025-09-30","value":"-4.42","vol":"2.98"},{"date":"2025-06-30","value":"-1.41","vol":"2.34"},{"date":"2025-03-31","value":"0.76","vol":"1.16"},{"date":"2024-12-31","value":"6.94","vol":"0.56"},{"date":"2024-09-30","value":"9.31","vol":"4.62"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-4.42 | -1.41 | 0.76 | 6.94 | 9.31 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.62 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"33.41","vol":"51.74"},{"date":"2025-06-30","value":"38.85","vol":"52.05"},{"date":"2025-03-31","value":"42.78","vol":"51.42"},{"date":"2024-12-31","value":"43.84","vol":"52.52"},{"date":"2024-09-30","value":"43.41","vol":"53.08"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
33.41 | 38.85 | 42.78 | 43.84 | 43.41 |
| 行业(%) | 51.74 | 52.05 | 51.42 | 52.52 | 53.08 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 129/242 ， 119/242。
[{"date":"2025-09-30","value":"-60.12","vol":"0.26"},{"date":"2025-06-30","value":"-60.07","vol":"-1.09"},{"date":"2025-03-31","value":"-72.47","vol":"-0.12"},{"date":"2024-12-31","value":"-11.63","vol":"1.15"},{"date":"2024-09-30","value":"12.10","vol":"0.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-60.12 | -60.07 | -72.47 | -11.63 | 12.10 |
| 行业(%) | 0.26 | -1.09 | -0.12 | 1.15 | 0.60 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-145.31","vol":"-15.37"},{"date":"2025-06-30","value":"-117.13","vol":"-18.14"},{"date":"2025-03-31","value":"-87.13","vol":"-2.59"},{"date":"2024-12-31","value":"-48.50","vol":"-23.09"},{"date":"2024-09-30","value":"-17.80","vol":"-9.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-145.31 | -117.13 | -87.13 | -48.50 | -17.80 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -9.60 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 96/242 ， 123/242。
[{"date":"2025-09-30","value":"0.16","vol":"0.25"},{"date":"2025-06-30","value":"0.12","vol":"0.17"},{"date":"2025-03-31","value":"0.06","vol":"0.08"},{"date":"2024-12-31","value":"0.38","vol":"0.36"},{"date":"2024-09-30","value":"0.37","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.16 | 0.12 | 0.06 | 0.38 | 0.37 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.58","vol":"1.66"},{"date":"2025-06-30","value":"0.39","vol":"1.12"},{"date":"2025-03-31","value":"0.18","vol":"0.55"},{"date":"2024-12-31","value":"1.19","vol":"2.32"},{"date":"2024-09-30","value":"1.25","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.58 | 0.39 | 0.18 | 1.19 | 1.25 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"-42.16","vol":"14.74"},{"date":"2025-06-30","value":"19.78","vol":"15.17"},{"date":"2025-03-31","value":"-22.87","vol":"4.22"},{"date":"2024-12-31","value":"10.90","vol":"29.38"},{"date":"2024-09-30","value":"-3.92","vol":"14.91"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -42.16 | 19.78 | -22.87 | 10.90 | -3.92 |
| 行业 | 14.74 | 15.17 | 4.22 | 29.38 | 14.91 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.23","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.43","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.23 | - | 0.43 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 52/242 ， 32/242。
[{"date":"2025-09-30","value":"3.58","vol":"5.66"},{"date":"2025-06-30","value":"3.09","vol":"5.47"},{"date":"2025-03-31","value":"2.90","vol":"5.84"},{"date":"2024-12-31","value":"2.64","vol":"5.30"},{"date":"2024-09-30","value":"1.92","vol":"5.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.58 | 3.09 | 2.90 | 2.64 | 1.92 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.73 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.79","vol":"4.51"},{"date":"2025-06-30","value":"1.64","vol":"4.35"},{"date":"2025-03-31","value":"1.50","vol":"4.73"},{"date":"2024-12-31","value":"1.49","vol":"4.27"},{"date":"2024-09-30","value":"1.17","vol":"4.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.79 | 1.64 | 1.50 | 1.49 | 1.17 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.60 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 23/242 ， 26/242。
[{"date":"2025-09-30","value":"31.92","vol":"22.07"},{"date":"2025-06-30","value":"33.93","vol":"22.01"},{"date":"2025-03-31","value":"28.51","vol":"21.19"},{"date":"2024-12-31","value":"34.07","vol":"21.94"},{"date":"2024-09-30","value":"31.73","vol":"21.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
31.92 | 33.93 | 28.51 | 34.07 | 31.73 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 21.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.47","vol":"0.71"},{"date":"2025-06-30","value":"0.51","vol":"0.58"},{"date":"2025-03-31","value":"0.40","vol":"0.56"},{"date":"2024-12-31","value":"0.52","vol":"0.55"},{"date":"2024-09-30","value":"0.46","vol":"0.38"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.47 | 0.51 | 0.40 | 0.52 | 0.46 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.38 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"2.10","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"2.62","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.76","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.42","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-0.28","blueLineValue":"-0.10","type":"YC"}]